journal
Journals Prostate Cancer and Prostatic ...

Prostate Cancer and Prostatic Diseases

https://read.qxmd.com/read/38902428/correction-editorial-comment-on-reevaluating-top-down-holep-the-case-for-anterior-fibromuscular-stroma-as-a-surgical-landmark
#1
Hazem Elmansy
No abstract text is available yet for this article.
June 20, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38902427/integrating-risk-calculators-into-routine-clinical-workflow-for-the-detection-of-prostate-cancer-next-steps-to-achieve-widespread-adoption
#2
EDITORIAL
Cody M Anger, James L Stallworth, Soroush Rais-Bahrami
No abstract text is available yet for this article.
June 20, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38898265/the-current-landscape-of-stereotactic-body-radiation-therapy-for-metastatic-castration-resistant-prostate-cancer
#3
REVIEW
Jennifer Le Guevelou, Francesco Cuccia, Ronan Flippot, Giuseppe Ferrera, Mario Terlizzi, Thomas Zilli, Renaud De Crevoisier, Jean-Michel Hannoun-Levi, Stephane Supiot, Paul Sargos, David Pasquier
BACKGROUND: The onset of castration-resistance is associated with dismal outcomes in patients with prostate cancer (PCa). Metastasis directed therapy has been investigated in multiple disease settings and may improve outcomes in selected patients. Our systematic review aims to summarize evidence with stereotactic body radiotherapy (SBRT) in castration-resistant prostate cancer (CRPC). METHODS: The literature search was performed on March 2024, on Pubmed, using the keywords "SBRT" AND "CRPC", and "stereotactic ablative radiotherapy (SABR)" AND "CRPC"...
June 19, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38890423/fatty-acid-diet-and-prostate-cancer-a-treasure-hunt-or-a-wild-goose-chase
#4
REVIEW
Georges Mjaess, Thierry Roumeguère, Kéziah Korpak, Pierre Van Antwerpen, Karim Zouaoui Boudjeltia
No abstract text is available yet for this article.
June 18, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38871841/can-chatgpt-provide-high-quality-patient-information-on-male-lower-urinary-tract-symptoms-suggestive-of-benign-prostate-enlargement
#5
JOURNAL ARTICLE
Angie K Puerto Nino, Valentina Garcia Perez, Silvia Secco, Cosimo De Nunzio, Riccardo Lombardo, Kari A O Tikkinen, Dean S Elterman
BACKGROUND: ChatGPT has recently emerged as a novel resource for patients' disease-specific inquiries. There is, however, limited evidence assessing the quality of the information. We evaluated the accuracy and quality of the ChatGPT's responses on male lower urinary tract symptoms (LUTS) suggestive of benign prostate enlargement (BPE) when compared to two reference resources. METHODS: Using patient information websites from the European Association of Urology and the American Urological Association as reference material, we formulated 88 BPE-centric questions for ChatGPT 4...
June 13, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38862777/nerve-sparing-radical-prostatectomy-using-the-neurovascular-structure-adjacent-frozen-section-examination-neurosafe-results-after-20-years-of-experience
#6
JOURNAL ARTICLE
Francesca Ambrosini, Felix Preisser, Derya Tilki, Hans Heinzer, Georg Salomon, Uwe Michl, Thomas Steuber, Tobias Maurer, Felix K H Chun, Lars Budäus, Randi M Pose, Carlo Terrone, Thorsten Schlomm, Pierre Tennstedt, Hartwig Huland, Markus Graefen, Alexander Haese
OBJECTIVES: To evaluate the long-term oncological outcomes and functional results of the neurovascular structure-adjacent frozen-section examination (NeuroSAFE) during nerve-sparing (NS) radical prostatectomy (RP). MATERIALS AND METHODS: A 10-yr survival analysis on 11069 RPs performed with or without the NeuroSAFE, between January 2002 to June 2011 was carried out. In the NeuroSAFE cohort, the neurovascular structure-adjacent prostatic margins are removed and stained for cryo-sectioning during RP...
June 11, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38862776/re-influence-of-anterior-fibromuscular-stroma-on-incontinence-outcomes-in-rasp-and-holep
#7
LETTER
Antonio Andrea Grosso, Daniele Amparore, Fabrizio Di Maida, Cristian Fiori, Agostino Tuccio, Francesco Porpiglia, Andrea Minervini
No abstract text is available yet for this article.
June 11, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38862775/setting-new-standards-robot-assisted-radical-prostatectomy-as-a-day-case
#8
REVIEW
Luca Orecchia, Georges Mjaess, Simone Albisinni
No abstract text is available yet for this article.
June 11, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38858447/evaluation-of-blood-and-urine-based-biomarkers-for-detection-of-clinically-significant-prostate-cancer
#9
REVIEW
Hunter S Robinson, Sangmyung S Lee, Daniel A Barocas, Jeffrey J Tosoian
BACKGROUND: Recognizing the limitations of prostate-specific antigen (PSA) screening and the morbidity of prostate biopsies, several blood- and urine-based biomarkers have been proposed for pre-biopsy risk stratification. These assays aim to reduce the frequency of unnecessary biopsies (i.e., negative or Grade Group 1 [GG1]) while maintaining highly sensitive detection of clinically significant cancer (GG ≥ 2) prostate cancer. METHODS: We reviewed the literature describing the use of currently available blood- and urine-based biomarkers for detection of GG ≥ 2 cancer, including the Prostate Health Index (PHI), 4Kscore, MyProstateScore (MPS), SelectMDx, ExoDx Prostate Intelliscore (EPI), and IsoPSA...
June 10, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38858446/detection-of-clinically-significant-prostate-cancer-following-initial-omission-of-biopsy-in-multiparametric-mri-era
#10
JOURNAL ARTICLE
Eric V Li, Anna M Busza, Mohammad R Siddiqui, Jonathan A Aguiar, Mary-Kate Keeter, Clayton Neill, Sai K Kumar, Xinlei Mi, Edward M Schaeffer, Hiten D Patel, Ashley E Ross
BACKGROUND: Multiparametric prostate MRI (mpMRI) is being increasingly adopted for work-up of prostate cancer. For patients selected to omit biopsy, we identified factors associated with repeat MRI, eventual prostate biopsy, and subsequent detection of clinically significant prostate cancer (csPCa, Grade Group ≥2). METHODS: We identified biopsy-naïve men presenting with PSA 2-20 ng/mL (March 2018-June 2021) undergoing initial mpMRI with PIRADS 1-3 lesions who were not selected for biopsy with ≥6 months follow-up...
June 10, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38830997/risk-calculators-for-the-detection-of-prostate-cancer-a-systematic-review
#11
JOURNAL ARTICLE
Frederique B Denijs, Meike J van Harten, Jonas J L Meenderink, Renée C A Leenen, Sebastiaan Remmers, Lionne D F Venderbos, Roderick C N van den Bergh, Katharina Beyer, Monique J Roobol
BACKGROUND: Prostate cancer (PCa) (early) detection poses significant challenges, including unnecessary testing and the risk of potential overdiagnosis. The European Association of Urology therefore suggests an individual risk-adapted approach, incorporating risk calculators (RCs) into the PCa detection pathway. In the context of 'The PRostate Cancer Awareness and Initiative for Screening in the European Union' (PRAISE-U) project ( https://uroweb.org/praise-u ), we aim to provide an overview of the currently available clinical RCs applicable in an early PCa detection algorithm...
June 3, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38822051/a-systematic-review-and-meta-analysis-to-evaluate-the-diagnostic-accuracy-of-psma-pet-ct-in-the-initial-staging-of-prostate-cancer
#12
REVIEW
Andrea Mari, Anna Cadenar, Sofia Giudici, Gemma Cianchi, Simone Albisinni, Riccardo Autorino, Fabrizio Di Maida, Giorgio Gandaglia, M Carmen Mir, Massimo Valerio, Giancarlo Marra, Fabio Zattoni, Lorenzo Bianchi, Riccardo Lombardo, Shahrokh F Shariat, Morgan Roupret, Matteo Bauckneht, Luca Vaggelli, Cosimo De Nunzio, Andrea Minervini
BACKGROUND: Positron Emission Tomography-Computed Tomography using Prostate-Specific Membrane Antigen (PSMA PET/CT) is notable for its superior sensitivity and specificity in detecting recurrent PCa and is under investigation for its potential in pre-treatment staging. Despite its established efficacy in nodal and metastasis staging in trial setting, its role in primary staging awaits fuller validation due to limited evidence on oncologic outcomes. This systematic review and meta-analysis aims to appraise the diagnostic accuracy of PSMA PET/CT compared to CI for comprehensive PCa staging...
May 31, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38806683/correction-real-world-four-year-functional-and-surgical-outcomes-of-rezum-therapy-in-younger-versus-elderly-men
#13
Michael Zhu, Mustufa Babar, Noah Hawks-Ladds, Marc-Mina Tawfik, Justin Loloi, Kevin Labagnara, Rahman Sayed, Kevin Tang, Azizou Salami, Sandeep Singh, Jaskirat Singh, Matthew Ines, Nazifa Iqbal, Michael Ciatto
No abstract text is available yet for this article.
May 28, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38796515/the-need-for-precision-medicine-in-managing-cardiovascular-risk-for-men-receiving-adt
#14
EDITORIAL
Andrew W Hahn, Efstratios Koutroumpakis, Vivek Narayan, Ana Aparicio
No abstract text is available yet for this article.
May 25, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38769422/letter-to-the-editor-incidence-of-prostate-cancer-in-transgender-women-in-the-us-a-large-database-analysis
#15
EDITORIAL
Wayne R Lawrence, Carl G Streed
No abstract text is available yet for this article.
May 20, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38744934/accuracy-readability-and-understandability-of-large-language-models-for-prostate-cancer-information-to-the-public
#16
JOURNAL ARTICLE
Jacob S Hershenhouse, Daniel Mokhtar, Michael B Eppler, Severin Rodler, Lorenzo Storino Ramacciotti, Conner Ganjavi, Brian Hom, Ryan J Davis, John Tran, Giorgio Ivan Russo, Andrea Cocci, Andre Abreu, Inderbir Gill, Mihir Desai, Giovanni E Cacciamani
BACKGROUND: Generative Pretrained Model (GPT) chatbots have gained popularity since the public release of ChatGPT. Studies have evaluated the ability of different GPT models to provide information about medical conditions. To date, no study has assessed the quality of ChatGPT outputs to prostate cancer related questions from both the physician and public perspective while optimizing outputs for patient consumption. METHODS: Nine prostate cancer-related questions, identified through Google Trends (Global), were categorized into diagnosis, treatment, and postoperative follow-up...
May 14, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38714781/baseline-serum-testosterone-and-differential-efficacy-of-bipolar-androgen-therapy-and-enzalutamide-in-the-randomized-transformer-trial
#17
JOURNAL ARTICLE
Mayuko Kanayama, Hua-Ling Tsai, Hao Wang, Emmanuel S Antonarakis, Samuel R Denmeade, Jun Luo
Bipolar androgen therapy (BAT) is effective in a subset of metastatic castration-resistant prostate cancer (mCRPC) patients. Treatment selection biomarkers are needed due to other therapies that can be equally efficacious. We performed post-hoc analysis to determine whether baseline serum testosterone (T) is a treatment selection marker in the TRANSFORMER study, a randomized trial of abiraterone-pretreated mCRPC patients assigned to BAT (n = 94) or enzalutamide (n = 101). The findings suggest that patients with poor outcomes to abiraterone and serum T ≥ 20 ng/dL may benefit preferentially from BAT over enzalutamide...
May 7, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38714780/incidence-and-management-of-bph-surgery-related-urethral-stricture-results-from-a-large-u-s-database
#18
JOURNAL ARTICLE
Leslie Claire Licari, Eugenio Bologna, Celeste Manfredi, Antonio Franco, Francesco Ditonno, Cosimo De Nunzio, Alessandro Antonelli, Giuseppe Simone, Marco De Sio, Luca Cindolo, Ephrem O Olweny, Edward E Cherullo, Costantino Leonardo, Riccardo Autorino
INTRODUCTION AND OBJECTIVES: Urethral stricture (US) is a well-known complication after surgical treatment of benign prostatic hyperplasia (BPH). This study aimed to evaluate the contemporary incidence of the US after different types of BPH surgery, to identify associated risk factors and to assess its management. METHODS: A retrospective analysis was conducted using the PearlDiver™ Mariner database, containing de-identified patient records compiled between 2011 and 2022...
May 7, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38684918/two-year-long-term-follow-up-of-treatment-with-the-optilume-bph-catheter-system-in-a-randomized-controlled-trial-for-benign-prostatic-hyperplasia-the-pinnacle-study
#19
JOURNAL ARTICLE
Steven A Kaplan, Jared L Moss, Sheldon J Freedman
BACKGROUND: Patient outcomes were assessed 2 years after treatment with the Optilume BPH Catheter System, a minimally invasive surgical therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). METHODS: One-hundred forty-eight adult males with symptomatic BPH were enrolled and randomized in a 2:1 fashion to Optilume BPH or Sham (100 Optilume BPH; 48 Sham). Long-term measures include International Prostate Symptom Score (IPSS), peak urinary flow rate (Qmax), Post-Void Residual Urine (PVR), quality of life measures and sexual function...
April 29, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38684917/benign-prostatic-hyperplasia-during-active-surveillance-for-prostate-cancer-is-it-time-to-define-management-strategies
#20
REVIEW
Eugenio Bologna, Leslie Claire Licari, Francesco Ditonno, Rocco Simone Flammia, Aldo Brassetti, Costantino Leonardo, Antonio Franco, Cosimo De Nunzio, Riccardo Autorino
No abstract text is available yet for this article.
April 29, 2024: Prostate Cancer and Prostatic Diseases
journal
journal
33118
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.